Haruhiko Hirate became Takeda’s Corporate Communications and Public Affairs Officer in October 2014. He previously served as President of North Asia in 2011, and has held Corporate Officer and Senior Vice President positions at Takeda since 2010.
Prior to joining Takeda, Mr. Hirate held the position of Representative Senior Managing Director at GlaxoSmithKline in Japan and, before that, Representative Director and President of Banyu Pharmaceuticals, the Japanese subsidiary of Merck & Co. He joined Banyu Pharmaceuticals in 2004 from his role as Senior Vice President at Merck & Co, based in the U.S. He had previously held the position of Representative Director and President at Roche Diagnostics based in Japan and before that, Asia Pacific Regional President of Draeger.
Mr. Hirate began his career with Nissei Sangyo, a subsidiary of Hitachi, in 1980. During his career at Hitachi group companies, he lived for about five years in Germany, mainly working with former Boehringer Manheim, and a series of overseas projects in the U.S. and Asia between 1980 and 1996.
Well respected in the Japanese pharmaceutical industry, Mr. Hirate served as Director at the Federation of Pharmaceutical Manufacturers Associations of Japan (FPMAJ), Standing Board of Director at the Japan Pharmaceutical Manufacturers Association (JPMA) and Chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) Japan. In 2012, he became a member of the Japan Association of Corporate Executives. In 2017, he became Vice Chairman of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Council.
He graduated from Keio University in Japan with a B.A. degree in economics in 1980.